ANI Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. 

CEO
Nikhil Lalwani
CEONikhil Lalwani
Employees
970
Employees970
Headquarters
Baudette, Minnesota
HeadquartersBaudette, Minnesota
Founded
1996
Founded1996
Employees
970
Employees970

ANIP Key Statistics

Market cap
1.58B
Market cap1.58B
Price-Earnings ratio
21.20
Price-Earnings ratio21.20
Dividend yield
Dividend yield
Average volume
459.79K
Average volume459.79K
High today
$72.90
High today$72.90
Low today
$70.15
Low today$70.15
Open price
$72.62
Open price$72.62
Volume
515.69K
Volume515.69K
52 Week high
$99.50
52 Week high$99.50
52 Week low
$56.71
52 Week low$56.71

Stock Snapshot

ANI Pharmaceuticals(ANIP) stock is priced at $70.49, giving the company a market capitalization of 1.58B. It carries a P/E multiple of 21.20.

On 2026-03-14, ANI Pharmaceuticals(ANIP) stock moved within a range of $70.15 to $72.90. With shares now at $70.49, the stock is trading +0.5% above its intraday low and -3.3% below the session's peak.

Trading activity shows a volume of 515.69K, compared to an average daily volume of 459.79K.

Over the past 52 weeks, ANI Pharmaceuticals(ANIP) stock has traded between a high of $99.50 and a low of $56.71.

Over the past 52 weeks, ANI Pharmaceuticals(ANIP) stock has traded between a high of $99.50 and a low of $56.71.

ANIP News

TipRanks 18h
Top Executive at ANI Pharmaceuticals Makes Attention-Grabbing Move With Company Stock

New insider activity at ANI Pharmaceuticals ( (ANIP) ) has taken place on March 13, 2026. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerf...

Simply Wall St 2d
How ANI’s Reaffirmed 2026 Guidance and Rare Disease Push Will Impact ANI Pharmaceuticals Investors

ANI Pharmaceuticals, Inc. recently reported fourth-quarter 2025 sales of US$247.06 million, up from US$190.57 million a year earlier, and moved from a net loss...

How ANI’s Reaffirmed 2026 Guidance and Rare Disease Push Will Impact ANI Pharmaceuticals Investors

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ANIP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.